Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 35Kidney Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Carcinoma, Non-Small-Cell Lung 6Melanoma 5Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Recurrence 3Lung Neoplasms 3Glioblastoma 3Carcinoma 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Sarcoma 2Pheochromocytoma 2Paraganglioma 2Liver Neoplasms 2Endometrial Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Adenoid Cystic 2cT2a N0NxM0 Renal Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Solitary Fibrous Tumors 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Relapsed Pediatric Solid Tumor 1Radiation Therapy 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 2encorafenib 1binimetinib 1alovudine 1X-Rays 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Platinum 1Nivolumab 1Metastasectomy 1Magnetic Resonance Spectroscopy 1Leuprolide 1Ipilimumab 1Goserelin 1Drug Therapy 1Docetaxel 1Axitinib 1Androgen Antagonists 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphatic Metastasis × Axitinib × Clear all
NCT01409200 2026-03-03

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

M.D. Anderson Cancer Center

Phase 2 Completed
73 enrolled

Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡